SCHEMBL3809696

SCHEMBL3809696

CCOc1cc(OC2CC3C(=O)NC(C(=O)OC)CCC=CCCCCCC(NC(=O)OC(C)(C)C)C(=O)[N+]3C2)c2cccc(Cl)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3373352 0.95 — —
SCHEMBL3373246 0.75 GAA (0.34) —
SCHEMBL16242435 0.75 EPHX2 (0.33) —
SCHEMBL3814397 0.74 GAA (0.31) —
SCHEMBL13757917 0.73 ADRB3 (0.49) —
SCHEMBL3809700 0.73 ADRB3 (0.49) —
SCHEMBL3809694 0.73 ADRB3 (0.49) —
SCHEMBL3369229 0.72 DDB1 (0.34) —
SCHEMBL3373349 0.71 ADRB3 (0.40) —
SCHEMBL13757916 0.71 ADRB3 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809267-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2014-08-19 — — US disclosed
US-20140051626-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2014-02-20 — — US disclosed
US-8513186-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2013-08-20 — — US disclosed
US-20090186869-A1 Antiviral compounds GILEAD SCIENCES, INC. (US) 2009-07-23 — — US disclosed
Send feedback